Shingles (Herpes Zoster) Vaccination Information for Healthcare Providers
ACIP vaccine recommendations for adults age 50 years old and older, and the contraindications and precautions for Shingrix vaccination
Information about Shingrix vaccine composition, dosage, and administration, and vaccine efficacy, duration of protection, reactogenicity
Answers to commonly asked questions about the new shingles vaccine
Information about Shingrix vaccine storage and handling
Information about administrating Shingrix with other vaccines, and how to avoid vaccine administration errors
Materials for patients and resources for healthcare providers
This fact sheet pdf icon[2 pages] describes who should get the shingles vaccine as well as the benefits and side effects. Zostavax is no longer available for use in the United States, as of November 18, 2020.